Index of /content/mda/en/newsroom/2022/01/relatlimab-plus-nivolumab-improves-progression-free-survival-in-metastatic-melanoma/

Name	Last Modified	Size
Parent Directory
jcr_content	2025-05-28 20:26	-

Proudly Served by LiteSpeed Web Server at www.mdandersoncellresearch.org Port 443